Healthcare provider profile · identity verified

Jonathan R Nelson, MD

Family Practice · SARTELL, MN · NPI 1336153725

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	961	250
Lisinopril	Lisinopril	472	132
Losartan Potassium	Losartan Potassium	417	115
Omeprazole	Omeprazole	417	109
Amlodipine Besylate	Amlodipine Besylate	399	100
Simvastatin	Simvastatin	370	97
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	359	102
Metoprolol Succinate	Metoprolol Succinate	343	96
Levothyroxine Sodium	Levothyroxine Sodium	287	64
Tamsulosin Hcl	Tamsulosin Hcl	252	70
Gabapentin	Gabapentin	243	46
Metformin Hcl	Metformin Hcl	232	66
Hydrochlorothiazide	Hydrochlorothiazide	211	60
Pantoprazole Sodium	Pantoprazole Sodium	209	57
Allopurinol	Allopurinol	180	46
Metoprolol Tartrate	Metoprolol Tartrate	174	42
Fluoxetine Hcl	Fluoxetine Hcl	155	32
Famotidine	Famotidine	148	31
Rosuvastatin Calcium	Rosuvastatin Calcium	136	43
Eliquis	Apixaban	130	30
Furosemide	Furosemide	128	35
Fluticasone Propionate	Fluticasone Propionate	115	38
Warfarin Sodium	Warfarin Sodium	107	29
Atenolol	Atenolol	105	28
Trazodone Hcl	Trazodone Hcl	104	34
Tramadol Hcl	Tramadol Hcl	97	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	94	19
Metformin Hcl Er	Metformin Hcl	91	28
Clopidogrel	Clopidogrel Bisulfate	90	27
Albuterol Sulfate Hfa	Albuterol Sulfate	89	38
Potassium Chloride	Potassium Chloride	85	23
Jardiance	Empagliflozin	77	15
Glipizide Er	Glipizide	75	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	23
Finasteride	Finasteride	71	17
Levetiracetam	Levetiracetam	69	suppressed
Prednisone	Prednisone	69	35
Triamcinolone Acetonide	Triamcinolone Acetonide	61	25
Pravastatin Sodium	Pravastatin Sodium	56	14
Citalopram Hbr	Citalopram Hydrobromide	54	17
Xarelto	Rivaroxaban	53	12
Mirtazapine	Mirtazapine	52	13
Sertraline Hcl	Sertraline Hcl	50	14
Ventolin Hfa	Albuterol Sulfate	49	18
Glipizide	Glipizide	48	11
Alprazolam	Alprazolam	45	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	13
Chlorthalidone	Chlorthalidone	43	13
Carvedilol	Carvedilol	42	15
Oxybutynin Chloride	Oxybutynin Chloride	42	suppressed
Gemfibrozil	Gemfibrozil	41	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Amoxicillin	Amoxicillin	39	21
Alendronate Sodium	Alendronate Sodium	38	11
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Lovastatin	Lovastatin	37	suppressed
Propranolol Hcl	Propranolol Hcl	37	suppressed
Torsemide	Torsemide	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	26
Meloxicam	Meloxicam	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Glimepiride	Glimepiride	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Trulicity	Dulaglutide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Digoxin	Digoxin	28	suppressed
Ozempic	Semaglutide	28	suppressed
Ketoconazole	Ketoconazole	27	18
Januvia	Sitagliptin Phosphate	26	suppressed
Loperamide	Loperamide Hcl	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Metolazone	Metolazone	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Colchicine	Colchicine	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Ramipril	Ramipril	17	suppressed
Flecainide Acetate	Flecainide Acetate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Naproxen	Naproxen	16	suppressed
Testosterone	Testosterone	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Procto-Med Hc	Hydrocortisone	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Estradiol	Estradiol	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lactulose	Lactulose	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error